Beam Therapeutics, Inc. (BEAM)
24.05
-0.51
(-2.08%)
USD |
NASDAQ |
Oct 23, 16:00
24.03
-0.02
(-0.08%)
After-Hours: 20:00
Beam Therapeutics Market Cap : 2.484B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.484B |
| October 22, 2026 | 2.536B |
| October 21, 2026 | 2.565B |
| October 20, 2026 | 2.574B |
| October 19, 2026 | 2.498B |
| October 16, 2026 | 2.424B |
| October 15, 2026 | 2.554B |
| October 14, 2026 | 2.442B |
| October 13, 2026 | 2.523B |
| October 12, 2026 | 2.595B |
| October 09, 2026 | 2.654B |
| October 08, 2026 | 2.540B |
| October 07, 2026 | 2.558B |
| October 06, 2026 | 2.605B |
| October 05, 2026 | 2.651B |
| October 02, 2026 | 2.530B |
| October 01, 2026 | 2.519B |
| September 30, 2026 | 2.525B |
| September 29, 2026 | 2.532B |
| September 28, 2026 | 2.502B |
| September 25, 2026 | 2.506B |
| September 24, 2026 | 2.547B |
| September 23, 2026 | 2.517B |
| September 22, 2026 | 2.678B |
| September 21, 2026 | 2.608B |
| Date | Value |
|---|---|
| September 18, 2026 | 2.576B |
| September 17, 2026 | 2.548B |
| September 16, 2026 | 2.385B |
| September 15, 2026 | 2.398B |
| September 14, 2026 | 2.491B |
| September 11, 2026 | 2.477B |
| September 10, 2026 | 2.517B |
| September 09, 2026 | 2.600B |
| September 08, 2026 | 2.771B |
| September 04, 2026 | 3.063B |
| September 03, 2026 | 3.042B |
| September 02, 2026 | 3.025B |
| September 01, 2026 | 2.997B |
| August 31, 2026 | 3.039B |
| August 28, 2026 | 3.028B |
| August 27, 2026 | 3.148B |
| August 26, 2026 | 3.118B |
| August 25, 2026 | 3.204B |
| August 24, 2026 | 2.925B |
| August 21, 2026 | 3.073B |
| August 20, 2026 | 2.932B |
| August 19, 2026 | 3.002B |
| August 18, 2026 | 2.744B |
| August 17, 2026 | 2.798B |
| August 14, 2026 | 2.762B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intellia Therapeutics, Inc. | 1.570B |
| Twist Bioscience Corp. | 8.769B |
| Prime Medicine, Inc. | 663.31M |
| Sarepta Therapeutics, Inc. | 1.873B |
| Q32 Bio, Inc. | 205.32M |
Market Cap Related Metrics
| PS Ratio | 15.99 |
| Price to Book Value | 2.327 |
| Price | 24.05 |
| Earnings Yield | -3.58% |